机构:[1]Capital Med Univ, Beijing Shijitan Hosp, Dept Gastrointestinal Surg, Beijing, Peoples R China[2]Capital Med Univ, Beijing Shijitan Hosp, Dept Clin Nutr, Beijing, Peoples R China[3]Capital Med Univ, Xuanwu Hosp, Natl Clin Res Ctr Geriatr Dis, Beijing, Peoples R China首都医科大学宣武医院[4]Key Lab Canc FSMP State Market Regulat, Beijing, Peoples R China[5]Capital Med Univ, Lab Clin Med, Beijing, Peoples R China[6]Shanghai Univ Med & Hlth Sci, Coll Publ Hlth, Shanghai, Peoples R China[7]Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA
Background Amino acids are known to play critical roles in cancer metabolism and progression. Among them, taurine, S-adenosylmethionine (SAM), and cysteine have garnered particular attention due to their interconnected metabolic pathways. This study sought to explore the associations between serum levels of these amino acids and cancer risk within Chinese adults.Methods A nested case-control study was conducted within the China H-Type Hypertension Registry Study cohort, comprising 1,391 cancer cases and 1,391 matched controls. Serum concentrations of taurine, SAM, and cysteine were quantified, and their associations with cancer risk were evaluated using conditional logistic regression and Bayesian Kernel Machine Regression (BKMR) models.Results A total of 1,391 pairs of participants were included in this study. Their average age was 69.3 years +/- 7.77 years, and 56% were male. Higher serum taurine levels were associated with a reduced risk of overall cancer. In contrast, elevated serum SAM levels were linked to an increased risk of digestive cancers. The BKMR model identified complex interactions among these amino acids and showed a significant overall negative association between the combined effect of taurine, SAM, and cysteine and cancer risk.Conclusion Serum taurine levels may offer protective benefits against cancer, particularly for digestive cancers, while its metabolites do not have such significant benefits. The intricate interactions among taurine, SAM, and cysteine underscore the need for a comprehensive approach to understanding their roles in the metabolic processes that drive tumorigenesis.Clinical Trial Registration https://www.chictr.org.cn/showproj.html?proj=28262, identifier ChiCTR1800017274.
基金:
National Key Research and Development Program [2022YFC2009600, 2022YFC2009601]; Laboratory for Clinical Medicine, Capital Medical University [2023-SYJCLC01]; National Multidisciplinary Cooperative Diagnosis and Treatment Capacity Project for Major Diseases [2019.YLFW]
第一作者机构:[1]Capital Med Univ, Beijing Shijitan Hosp, Dept Gastrointestinal Surg, Beijing, Peoples R China[2]Capital Med Univ, Beijing Shijitan Hosp, Dept Clin Nutr, Beijing, Peoples R China[3]Capital Med Univ, Xuanwu Hosp, Natl Clin Res Ctr Geriatr Dis, Beijing, Peoples R China[4]Key Lab Canc FSMP State Market Regulat, Beijing, Peoples R China[5]Capital Med Univ, Lab Clin Med, Beijing, Peoples R China
共同第一作者:
通讯作者:
通讯机构:[1]Capital Med Univ, Beijing Shijitan Hosp, Dept Gastrointestinal Surg, Beijing, Peoples R China[2]Capital Med Univ, Beijing Shijitan Hosp, Dept Clin Nutr, Beijing, Peoples R China[3]Capital Med Univ, Xuanwu Hosp, Natl Clin Res Ctr Geriatr Dis, Beijing, Peoples R China[4]Key Lab Canc FSMP State Market Regulat, Beijing, Peoples R China[5]Capital Med Univ, Lab Clin Med, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Liu Chenan,Liu Tong,Wei Yaping,et al.Interplay of serum taurine, S-adenosylmethionine, and cysteine levels in cancer risk: a prospective study[J].FRONTIERS IN PHARMACOLOGY.2024,15:doi:10.3389/fphar.2024.1507125.
APA:
Liu, Chenan,Liu, Tong,Wei, Yaping,Shi, Jinyu,Deng, Li...&Shi, Hanping.(2024).Interplay of serum taurine, S-adenosylmethionine, and cysteine levels in cancer risk: a prospective study.FRONTIERS IN PHARMACOLOGY,15,
MLA:
Liu, Chenan,et al."Interplay of serum taurine, S-adenosylmethionine, and cysteine levels in cancer risk: a prospective study".FRONTIERS IN PHARMACOLOGY 15.(2024)